Middle East respiratory syndrome coronavirus (MERS-CoV), 11 June 2015
This update was prompted by the recent increase in the number of confirmed MERS-CoV cases in South Korea. The South Korean disease cluster was generated by a primary case imported from the Middle East and is the largest cluster observed outside of the Arabian Peninsula so far.
he cluster of Middle East respiratory syndrome coronavirus (MERS-CoV) continues to evolve in South Korea, where 107 confirmed cases and nine deaths have been reported as of 10 June 2015 and since the first case was diagnosed on 20 May 2015. While it is the largest cluster of MERS-CoV seen outside of the Arabian Peninsula, it follows the pattern of transmission in Saudi Arabian hospitals when extended nosocomial transmission was observed, and is thus not unexpected.
ECDC’s latest assessment continues to conclude that the current MERS-CoV outbreak poses a low risk to the EU. It highlights the importance of rapid consideration of MERS-CoV and strict adherence to infection control measures in healthcare settings, as well as suggests raising travellers’ awareness of the presence of MERS-CoV in the Middle East and in South Korea.
Risk to travellers to South Korea
The outbreak so far does not represent an increased risk of infection for travellers or visitors to South Korea. However, EU citizens travelling to the Middle East and South Korea need to be aware of the presence of MERS-CoV in these areas, especially in healthcare facilities, as continued exposure in affected healthcare facilities cannot be excluded. Travellers who have visited healthcare facilities in the Middle East and South Korea who develop respiratory symptoms up to 14 days after return should seek medical attention, indicating their travel history.
Surveillance and infection control of paramount importance
ECDC risk assessment once again reasserts the importance of international surveillance for MERS-CoV cases among travelers. Rapid efforts to contain nosocomial clusters in the Middle East and South Korea are vital to prevent broader transmission.
Rigorous implementation of infection prevention and control measures in hospitals is essential to interrupt transmission and prevent clusters of infection. Detecting rare imported cases early on is a challenge that highlights the need for adequate infection prevention and control measures for all patients showing symptoms of acute respiratory infection.
Continued investigation needed
Additional information on clinical presentation, further details on epidemiological features of the cluster, and knowledge of MERS-CoV genetic sequences are required to confirm our current conclusions. In addition, more details on the potential exposure in the community of the index case would help to elucidate the potential source of the infection and the cause of the high number of secondary cases.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
2 Jul 2019 - In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
Rapid risk assessment: Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), 22nd update
29 Aug 2018 - This update of ECDC’s risk assessment on MERS-CoV was triggered by the detection of a case imported into the EU/EEA from the Kingdom of Saudi Arabia (KSA). In this update, we reassess the risk for EU/EEA residents.
Rapid Risk Assessment: Public health risks related to communicable diseases during the Hajj 2017, Saudi Arabia, 30 August – 4 September 2017
10 Aug 2017 - This document assesses the potential risk of outbreaks and transmission of communicable diseases during the Hajj taking place between 30 August and 4 September 2017.